Tag: Janumet

Over 38 million Americans have diabetes, and many rely on combination medications like Janumet or JENTADUETO for management. While both drugs combine a DPP-4 inhibitor with metformin to improve glycemic control, the key difference lies in the specific DPP-4 inhibitor they contain.

For the millions of Americans with Type 2 diabetes, controlling blood glucose can require more than one medication. When diet and exercise, and a single drug like metformin, aren't enough, clinicians often add a second agent. For those considering or already taking the DPP-4 inhibitor Januvia (sitagliptin), the question of what is the best combination with Januvia is a critical next step for personalized treatment.